Market News

Truist Securities analyst Srikripa Devarakonda upgrades Biogen (NASDAQ:BIIB) from Hold to Buy and raises the price target from $190 to $235.

Stitch Fix (SFIX) rebound case: Q3 customer growth, higher margins, raised guidance, and deep-value valuation with debt-free balance sheet—read now.

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates CervoMed (NASDAQ:CRVO) with a Buy and maintains $25 price target.

Bitcoin, gold, and silver have different long-run fundamentals. Over the past two months, however, they have traded off the same short-run macro impul...

Compass Diversified (NYSE:CODI) ("CODI" or the "Company"), an owner of leading middle market businesses, today announced that it has e...

Progress Software (PRGS) rated neutral with 6% upside to $40 target.

HC Wainwright & Co. analyst Yi Chen initiates coverage on Apyx Medical (NASDAQ:APYX) with a Buy rating and announces Price Target of $7.

HC Wainwright & Co. analyst Yi Chen maintains OKYO Pharma (NASDAQ:OKYO) with a Buy and lowers the price target from $7 to $5.

Jefferies upgraded the stock to Buy with a $160 target price, following a similar upgrade from Stifel.

Capri Holdings recently presented at Bernstein Insights’ 2nd Annual Retail Forum in New York, where Chairman & CEO John D. Idol and CFO & COO Tyler Re...

Amrize is rated a cautious Buy, supported by strong Building Materials performance and a $1B buyback program. Click to read this latest analysis of AM...

Gamehaus Holdings Inc. ("Gamehaus" or the "Company") (NASDAQ:GMHS), a technology-driven mobile game publisher, today announced that it...

HC Wainwright & Co. analyst Emily Bodnar maintains Hemab Therapeutics Hldgs (NASDAQ:COAG) with a Buy and raises the price target from $40 to $5...

Northern Oil and Gas, Inc. (NYSE:NOG) ("NOG" or the "Company") today provided an update on several business matters including second q...

RPM International (RPM) gets a Buy: resilient maintenance demand, $75M savings plan, margin upside, and $110–$122 target range.

The early-2026 macro tailwinds have shifted, the Middle East conflict reignited energy-driven inflation, and pushed the dollar higher on safe-haven de...

Agenus Inc. (NASDAQ:AGEN), a leader in immuno-oncology innovation, today announced that it has entered into a securities purchase agreement for a priv...

Company Receives Expanded Permit to Fly from UK Civil Aviation Authority for first public demonstration flightsCompany to Host Investor Meetings Durin...

The platform combines fund discovery, portfolio management, analytics and benchmarking tools within a single system.

PARIS, July 13, 2026--Sofinnova Partners ("Sofinnova"), a leading European venture capital firm in life sciences, based in Paris, London, and Milan, a...